Bioanalytical Systems Company Profile (NASDAQ:BASI)

About Bioanalytical Systems

Bioanalytical Systems logo

Bioanalytical Systems, Inc. (BASi) is a contract research organization (CRO) providing drug discovery and development services and analytical instruments. The Company operates through two segments: contract research services and research products. Its contract research services segment provides research and development support on a contract basis directly to pharmaceutical companies. Its research products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Its Culex family of robotic automated dose delivery, blood and other biofluids sampling and physiological parameters measurement systems enable researchers to determine pharmacokinetic/pharmacodynamic (PK/PD) profiles of drugs in large and small animal models. The Company's bioanalytical services group supports research, preclinical and clinical programs.

Industry, Sector and Symbol:

Sector: Medical
Industry: Research Services
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: BASI
CUSIP:

Key Metrics:

Previous Close: $1.17
50 Day Moving Average: $1.16
200 Day Moving Average: $1.12
52-Week Range: $0.90 - $1.78
Trailing P/E Ratio: N/A
P/E Growth: 0.00
Market Cap: $9.32M
Outstanding Shares: 8,107,000
Beta: 0.95

Profitability:

Net Margins: -9.45%
Return on Equity: -21.55%
Return on Assets: -8.31%

Debt:

Debt-to-Equity Ratio: 0.03%
Current Ratio: 0.46%
Quick Ratio: 0.35%

Additional Links:

Companies Related to Bioanalytical Systems:

Consensus Ratings for Bioanalytical Systems (NASDAQ:BASI) (?)

Ratings Breakdown:	No ratings tracked in the last 12 months.
Consensus Rating:	N/A (Score: NaN)
Consensus Price Target:	N/A

Analysts' Ratings History for Bioanalytical Systems (NASDAQ:BASI)

Show:

No equities research coverage for this company has been tracked by MarketBeat.com

Earnings History for Bioanalytical Systems (NASDAQ:BASI)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
12/15/2016
8/11/2016	Q316		($0.05)	$6.15 million	$5.05 million	View	Listen
5/12/2016	Q216		($0.03)	$5.73 million	$5.34 million	View	Listen
2/16/2016	Q116		($0.06)	$5.95 million	$4.90 million	View	Listen
12/17/2015	Q415		($0.09)	$6.42 million	$4.98 million	View	Listen
8/13/2015	Q315		$0.16	$6.03 million	$6.15 million	View	Listen
5/14/2015	Q215		($0.01)	$5.92 million	$5.73 million	View	Listen
2/12/2015	Q115		$0.01	$6.22 million	$5.85 million	View	N/A
12/22/2014	Q414		($0.02)		$6.42 million	View	N/A
8/14/2014	Q314		$0.02	$5.60 million	$6.03 million	View	N/A
5/15/2014	Q2		($0.03)	$5.16 million	$5.91 million	View	Listen
2/13/2014	Q114		$0.04	$5.80 million	$6.22 million	View	N/A
12/24/2013	Q4 13		$0.03	$6.54 million	$5.51 million	View	N/A
10/18/2013	Q313	$0.01	$0.07	$5.65 million	$5.60 million	View	N/A
5/15/2013	Q2 2013	$0.01	($0.02)	$5.74 million	$5.16 million	View	Listen
2/14/2013	Q1 2013	($0.03)	$0.02	$6.65 million	$5.80 million	View	Listen

(Data available from 1/1/2011 forward)

Earnings Estimates for Bioanalytical Systems (NASDAQ:BASI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Bioanalytical Systems (NASDAQ:BASI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Bioanalytical Systems (NASDAQ:BASI)

Insider Ownership Percentage: 4.00%
Institutional Ownership Percentage: 2.87%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
5/27/2016	Connie Leigh Dougherty	VP	Buy	423	$0.92	$389.16
5/23/2016	Connie Leigh Dougherty	VP	Buy	96	$0.92	$88.32
5/19/2016	Connie Leigh Dougherty	VP	Buy	1,655	$0.92	$1,522.60
2/29/2016	Jacqueline M Lemke	CEO	Buy	10,000	$1.18	$11,800.00
9/14/2015	Philip A Downing	VP	Buy	3,000	$1.73	$5,190.00
2/27/2015	Jacqueline M Lemke	CEO	Buy	10,000	$2.04	$20,400.00
6/13/2014	John P Devine	VP	Sell	3,130	$2.64	$8,263.20
8/17/2012	David L Omachinski	Director	Buy	10,000	$1.26	$12,600.00
8/17/2012	Jacqueline M Lemke	CEO	Buy	20,000	$1.26	$25,200.00

(Data available from 1/1/2013 forward)

Latest Headlines for Bioanalytical Systems (NASDAQ:BASI)

Date	Headline
	BASi introduces Embrace Automation grant programme with Culex NxT Automated Blood Sampling system (NASDAQ:BASI) pharmabiz.com - August 29 at 4:19 PM
	Bioanalytical : BASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System (NASDAQ:BASI) www.4-traders.com - August 26 at 3:41 PM
	Bioanalytical (BASI) Launches Sampling System, Stock Down (NASDAQ:BASI) finance.yahoo.com - August 26 at 3:41 PM
	BASi Launches Embrace Automation Grant Program With Culex NxT Automated Blood Sampling System (NASDAQ:BASI) www.laboratorynetwork.com - August 26 at 11:51 AM
	BASi Launches Embrace Automation Grant Program with Culex NxT™ Automated Blood Sampling System (NASDAQ:BASI) finance.yahoo.com - August 25 at 8:35 AM
	Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q3, 2016 By the Numbers : August 15, 2016 (NASDAQ:BASI) www.capitalcube.com - August 15 at 3:53 PM
	BASi Reports Third Quarter Results (NASDAQ:BASI) www.digitaljournal.com - August 12 at 12:20 PM
	BRIEF-Basi Q3 loss per share $0.05 (NASDAQ:BASI) www.reuters.com - August 12 at 12:20 PM
	Bioanalytical Systems to Release Third Quarter Fiscal 2016 Results on Thursday, August 11, 2016; Conference Call & Webcast Set For 11:00 a.m. EST (NASDAQ:BASI) www.publicnow.com - August 5 at 9:07 PM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure (NASDAQ:BASI) biz.yahoo.com - August 4 at 3:50 PM
	Bioanalytical Systems to Release Third Quarter Fiscal 2016 Results on Thursday, August 11, 2016; Conference Call & Webcast Set For 11:00 am EDT (NASDAQ:BASI) finance.yahoo.com - August 3 at 12:21 PM
	Bioanalytical Systems : BASi Expands Electrochemical Offerings by Partnering with PalmSens BV (NASDAQ:BASI) www.4-traders.com - July 27 at 12:16 PM
	BASi Expands Electrochemical Offerings by Partnering with PalmSens BV (NASDAQ:BASI) finance.yahoo.com - July 27 at 8:30 AM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure (NASDAQ:BASI) biz.yahoo.com - July 22 at 3:12 PM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:BASI) biz.yahoo.com - July 6 at 1:19 PM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:BASI) biz.yahoo.com - July 6 at 1:19 PM
	Edited Transcript of BASI earnings conference call or presentation 12-May-16 3:00pm GMT (NASDAQ:BASI) finance.yahoo.com - May 18 at 6:53 AM
	Bioanalytical Systems, Inc. :BASI-US: Earnings Analysis: Q2, 2016 By the Numbers (NASDAQ:BASI) www.capitalcube.com - May 13 at 11:58 AM
	BASi Reports Second Quarter Results (NASDAQ:BASI) finance.yahoo.com - May 12 at 9:56 AM
	Q2 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open (NASDAQ:BASI) biz.yahoo.com - May 12 at 7:07 AM
	Bioanalytical Systems, Inc. Announces Appointment of New Chief Financial Officer (NASDAQ:BASI) finance.yahoo.com - May 11 at 11:01 AM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex (NASDAQ:BASI) biz.yahoo.com - May 4 at 1:16 PM
	Bioanalytical Systems to Release Second Quarter Fiscal 2016 Results on Thursday, May 12, 2016; Conference Call & Webcast Set For 11:00 a.m. EDT (NASDAQ:BASI) www.publicnow.com - May 4 at 10:50 AM
	BASi Launches New Website and E-Catalogue (NASDAQ:BASI) finance.yahoo.com - April 14 at 2:10 PM
	CORRECTING and REPLACING BASi Introduces the Next Generation of Electrochemical Analyzer With the Release of the Epsilon EClipse™ (NASDAQ:BASI) finance.yahoo.com - March 29 at 1:08 PM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:BASI) biz.yahoo.com - March 16 at 3:52 PM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:BASI) biz.yahoo.com - March 4 at 1:25 PM
	Bioanalytical Systems, Inc. Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:BASI) www.capitalcube.com - February 18 at 11:12 AM
	Edited Transcript of BASI earnings conference call or presentation 16-Feb-16 4:00pm GMT (NASDAQ:BASI) finance.yahoo.com - February 17 at 11:10 AM
	Bioanalytical Systems Loss Widens in Q1, Revenues Fall (NASDAQ:BASI) finance.yahoo.com - February 17 at 10:40 AM
	Bioanalytical Systems : BASi Reports First Quarter Results (NASDAQ:BASI) www.4-traders.com - February 16 at 1:41 PM
	BASi Reports Fiscal Q1 Loss (NASDAQ:BASI) www.insideindianabusiness.com - February 16 at 1:41 PM
	BASi Reports First Quarter Results (NASDAQ:BASI) finance.yahoo.com - February 16 at 9:00 AM
	Q1 2016 Bioanalytical Systems Inc Earnings Release - Before Market Open (NASDAQ:BASI) biz.yahoo.com - February 16 at 7:07 AM
	Basi Awards Three Sampling Systems for Full Animal Response Profiles (NASDAQ:BASI) www.photonics.com - February 12 at 1:32 PM
	Bioanalytical Systems, Inc.: Gathering momentum, but may lack support (NASDAQ:BASI) www.capitalcube.com - February 11 at 4:20 PM
	Bioanalytical Systems to Release First Quarter Fiscal 2016 Results on Tuesday, February 16, 2016; Conference Call & Webcast Set For 11:00 a.m. EST (NASDAQ:BASI) finance.yahoo.com - February 9 at 10:00 AM
	BASi Awards Raturn® Systems for Optogenetic Research (NASDAQ:BASI) finance.yahoo.com - February 4 at 11:50 AM
	Bioanalytical Systems Inc. (BASI) (NASDAQ:BASI) finance.yahoo.com - January 31 at 6:47 PM
	BIOANALYTICAL SYSTEMS INC Files SEC form 10-K, Annual Report (NASDAQ:BASI) biz.yahoo.com - December 24 at 12:27 PM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and (NASDAQ:BASI) biz.yahoo.com - December 22 at 3:56 PM
	BASi Reports Fiscal 2015 Full Year and Fourth Quarter Results (NASDAQ:BASI) finance.yahoo.com - December 17 at 9:01 AM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:BASI) biz.yahoo.com - December 15 at 1:34 PM
	BASi Names Dawn M. Joseph Director of Business Development (NASDAQ:BASI) finance.yahoo.com - December 15 at 11:00 AM
	BASi Names Wendy Perrow to Board of Directors (NASDAQ:BASI) finance.yahoo.com - December 14 at 10:30 AM
	Bioanalytical Systems to Release Fourth Quarter and Full Year Fiscal 2015 Results on Thursday, December 17, 2015; Conference Call & Webcast Set For 11:00 a.m. EST (NASDAQ:BASI) finance.yahoo.com - December 3 at 3:45 PM
	BIOANALYTICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exh (NASDAQ:BASI) biz.yahoo.com - November 19 at 4:52 PM
	Bioanalytical Systems, Inc. Earnings Q3, 2015 (NASDAQ:BASI) www.capitalcube.com - September 21 at 11:28 AM
	BIOANALYTICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:BASI) biz.yahoo.com - August 14 at 3:36 PM
	BASi Reports Third Quarter Net Income of $0.16 per Share (NASDAQ:BASI) finance.yahoo.com - August 13 at 8:45 AM